Aerie Pharmaceuticals, Inc. - AERI - Fundamentals

‌
‌

‌

Let's get started...

‌

Breakdown	2011 12/31	2012 12/31	2013 12/31	2014 12/31	2015 12/31	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	TTM
REVENUE	0	0	0	0	0	0	0	24	70	83	194	214	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	--	+189.02%	+18.96%	+133.51%	+10.20%	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	0	0	0	1	5	25	27	24	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	--	--	--	+653.98%	+424.17%	+5.97%	-12.39%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	0	0	0	0	24	65	58	167	190	📊
Gross Profit Growth (1Y)	--	--	--	--	--	--	--	--	+176.36%	-11.14%	+189.40%	+13.83%	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	14	14	22	50	75	97	146	233	253	213	214	217	📊
Operating Expenses Growth (1Y)	--	+0.54%	+55.11%	+125.40%	+50.26%	+29.01%	+50.40%	+60.12%	+8.26%	-15.46%	+0.07%	+1.63%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+428.18%	+577.76%	+557.16%	+366.83%	+236.34%	+120.39%	+46.64%	+49.03%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+1401.79%	+1394.73%	+1419.16%	📊
Sell General Administrative	4	5	10	20	31	44	74	121	138	137	138	130	📊
Research and Development	11	9	12	30	44	52	72	86	91	74	76	88	📊
Other Income Expenses	0	0	0	0	0	0	0	27	23	2	0	--	📊
EBITDA	-13	-15	-27	-47	-71	-95	-143	-228	-166	-117	-8	-3	📊
EBITDA Growth (1Y)	--	-15.91%	-84.82%	-73.81%	-50.70%	-33.41%	-50.05%	-59.06%	+26.93%	+29.51%	+93.33%	+60.66%	📊
EBITDA Growth (5Y)	--	--	--	--	-461.15%	-545.84%	-424.33%	-379.83%	-132.66%	-22.93%	+94.54%	+97.85%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-820.25%	+47.08%	+79.18%	📊
Depreciation and Amortization	0	0	0	0	0	1	1	2	18	34	38	20	📊
Operating Income	-14	-14	-22	-50	-75	-97	-146	-210	-187	-156	-45	-23	📊
Operating Income Growth (1Y)	--	-0.54%	-55.11%	-125.40%	-50.26%	-29.01%	-50.40%	-43.96%	+10.61%	+16.96%	+70.90%	+48.71%	📊
Operating Income Growth (5Y)	--	--	--	--	-428.18%	-577.76%	-557.16%	-319.72%	-149.70%	-60.72%	+68.90%	+84.05%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-995.17%	-217.03%	-62.60%	📊
Interest Expense	0	0	4	1	2	3	2	3	15	26	29	12	📊
Pre Tax Income	-13	-15	-31	-48	-74	-99	-147	-233	-200	-178	-74	-35	📊
Tax Provision	1	-1	-5	2	0	0	-2	0	-0	5	1	1	📊
NET INCOME	-13	-15	-31	-48	-74	-99	-145	-233	-200	-183	-75	-37	📊
Net Income Growth (1Y)	--	-15.51%	-107.96%	-54.53%	-54.49%	-33.21%	-46.48%	-60.28%	+14.18%	+8.26%	+59.14%	+51.14%	📊
Net Income Growth (5Y)	--	--	--	--	-473.48%	-561.36%	-365.86%	-383.18%	-168.39%	-84.84%	+48.44%	+74.81%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-1312.05%	-399.47%	-144.06%	📊
Basic EPS	-0.82	-0.95	-6.29	-2	-2.88	-3.4	-4.11	-5.58	-4.39	-3.99	-1.61	-0.75	📊
Diluted EPS	-0.82	-0.95	-6.29	-2	-2.88	-3.4	-4.11	-5.58	-4.39	-3.99	-1.61	-0.77	📊
Basic Average Shares	16	16	5	24	26	29	35	42	45	46	46	47	📊
Diluted Average Shares	16	16	5	24	26	29	35	42	45	46	46	48	📊

Breakdown

2011

12/31

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

TTM

REVENUE

194

214

📊

Revenue Growth (1Y)

+189.02%

+18.96%

+133.51%

+10.20%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+653.98%

+424.17%

+5.97%

-12.39%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

167

190

📊

Gross Profit Growth (1Y)

+176.36%

-11.14%

+189.40%

+13.83%

📊

Gross Profit Growth (5Y)

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

146

233

253

213

214

217

📊

Operating Expenses Growth (1Y)

+0.54%

+55.11%

+125.40%

+50.26%

+29.01%

+50.40%

+60.12%

+8.26%

-15.46%

+0.07%

+1.63%

📊

Operating Expenses Growth (5Y)

+428.18%

+577.76%

+557.16%

+366.83%

+236.34%

+120.39%

+46.64%

+49.03%

📊

Operating Expenses Growth (10Y)

+1401.79%

+1394.73%

+1419.16%

📊

Sell General Administrative

121

138

137

138

130

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

-13

-15

-27

-47

-71

-95

-143

-228

-166

-117

-8

-3

📊

EBITDA Growth (1Y)

-15.91%

-84.82%

-73.81%

-50.70%

-33.41%

-50.05%

-59.06%

+26.93%

+29.51%

+93.33%

+60.66%

📊

EBITDA Growth (5Y)

-461.15%

-545.84%

-424.33%

-379.83%

-132.66%

-22.93%

+94.54%

+97.85%

📊

EBITDA Growth (10Y)

-820.25%

+47.08%

+79.18%

📊

Depreciation and Amortization

📊

Operating Income

-14

-22

-50

-75

-97

-146

-210

-187

-156

-45

-23

📊

Operating Income Growth (1Y)

-0.54%

-55.11%

-125.40%

-50.26%

-29.01%

-50.40%

-43.96%

+10.61%

+16.96%

+70.90%

+48.71%

📊

Operating Income Growth (5Y)

-428.18%

-577.76%

-557.16%

-319.72%

-149.70%

-60.72%

+68.90%

+84.05%

📊

Operating Income Growth (10Y)

-995.17%

-217.03%

-62.60%

📊

Interest Expense

📊

Pre Tax Income

-13

-15

-31

-48

-74

-99

-147

-233

-200

-178

-74

-35

📊

Tax Provision

-1

-5

-2

-0

📊

NET INCOME

-13

-15

-31

-48

-74

-99

-145

-233

-200

-183

-75

-37

📊

Net Income Growth (1Y)

-15.51%

-107.96%

-54.53%

-54.49%

-33.21%

-46.48%

-60.28%

+14.18%

+8.26%

+59.14%

+51.14%

📊

Net Income Growth (5Y)

-473.48%

-561.36%

-365.86%

-383.18%

-168.39%

-84.84%

+48.44%

+74.81%

📊

Net Income Growth (10Y)

-1312.05%

-399.47%

-144.06%

📊

Basic EPS

-0.82

-0.95

-6.29

-2

-2.88

-3.4

-4.11

-5.58

-4.39

-3.99

-1.61

-0.75

📊

Diluted EPS

-0.82

-0.95

-6.29

-2

-2.88

-3.4

-4.11

-5.58

-4.39

-3.99

-1.61

-0.77

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2011 12/31	2012 12/31	2013 12/31	2014 12/31	2015 12/31	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2021 12/31	TTM
REVENUE	0	0	0	0	0	0	0	24	70	83	194	214	📊
Revenue Growth (1Y)	--	--	--	--	--	--	--	--	+189.02%	+18.96%	+133.51%	+10.20%	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue	0	0	0	0	0	0	0	1	5	25	27	24	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	--	--	--	+653.98%	+424.17%	+5.97%	-12.39%	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	0	0	0	0	24	65	58	167	190	📊
Gross Profit Growth (1Y)	--	--	--	--	--	--	--	--	+176.36%	-11.14%	+189.40%	+13.83%	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Operating Expenses	14	14	22	50	75	97	146	233	253	213	214	217	📊
Operating Expenses Growth (1Y)	--	+0.54%	+55.11%	+125.40%	+50.26%	+29.01%	+50.40%	+60.12%	+8.26%	-15.46%	+0.07%	+1.63%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+428.18%	+577.76%	+557.16%	+366.83%	+236.34%	+120.39%	+46.64%	+49.03%	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+1401.79%	+1394.73%	+1419.16%	📊
Sell General Administrative	4	5	10	20	31	44	74	121	138	137	138	130	📊
Research and Development	11	9	12	30	44	52	72	86	91	74	76	88	📊
Other Income Expenses	0	0	0	0	0	0	0	27	23	2	0	--	📊
EBITDA	-13	-15	-27	-47	-71	-95	-143	-228	-166	-117	-8	-3	📊
EBITDA Growth (1Y)	--	-15.91%	-84.82%	-73.81%	-50.70%	-33.41%	-50.05%	-59.06%	+26.93%	+29.51%	+93.33%	+60.66%	📊
EBITDA Growth (5Y)	--	--	--	--	-461.15%	-545.84%	-424.33%	-379.83%	-132.66%	-22.93%	+94.54%	+97.85%	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	-820.25%	+47.08%	+79.18%	📊
Depreciation and Amortization	0	0	0	0	0	1	1	2	18	34	38	20	📊
Operating Income	-14	-14	-22	-50	-75	-97	-146	-210	-187	-156	-45	-23	📊
Operating Income Growth (1Y)	--	-0.54%	-55.11%	-125.40%	-50.26%	-29.01%	-50.40%	-43.96%	+10.61%	+16.96%	+70.90%	+48.71%	📊
Operating Income Growth (5Y)	--	--	--	--	-428.18%	-577.76%	-557.16%	-319.72%	-149.70%	-60.72%	+68.90%	+84.05%	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-995.17%	-217.03%	-62.60%	📊
Interest Expense	0	0	4	1	2	3	2	3	15	26	29	12	📊
Pre Tax Income	-13	-15	-31	-48	-74	-99	-147	-233	-200	-178	-74	-35	📊
Tax Provision	1	-1	-5	2	0	0	-2	0	-0	5	1	1	📊
NET INCOME	-13	-15	-31	-48	-74	-99	-145	-233	-200	-183	-75	-37	📊
Net Income Growth (1Y)	--	-15.51%	-107.96%	-54.53%	-54.49%	-33.21%	-46.48%	-60.28%	+14.18%	+8.26%	+59.14%	+51.14%	📊
Net Income Growth (5Y)	--	--	--	--	-473.48%	-561.36%	-365.86%	-383.18%	-168.39%	-84.84%	+48.44%	+74.81%	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	-1312.05%	-399.47%	-144.06%	📊
Basic EPS	-0.82	-0.95	-6.29	-2	-2.88	-3.4	-4.11	-5.58	-4.39	-3.99	-1.61	-0.75	📊
Diluted EPS	-0.82	-0.95	-6.29	-2	-2.88	-3.4	-4.11	-5.58	-4.39	-3.99	-1.61	-0.77	📊
Basic Average Shares	16	16	5	24	26	29	35	42	45	46	46	47	📊
Diluted Average Shares	16	16	5	24	26	29	35	42	45	46	46	48	📊

Breakdown

2011

12/31

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2021

12/31

TTM

REVENUE

194

214

📊

Revenue Growth (1Y)

+189.02%

+18.96%

+133.51%

+10.20%

📊

Revenue Growth (5Y)

📊

Revenue Growth (10Y)

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

+653.98%

+424.17%

+5.97%

-12.39%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

167

190

📊

Gross Profit Growth (1Y)

+176.36%

-11.14%

+189.40%

+13.83%

📊

Gross Profit Growth (5Y)

📊

Gross Profit Growth (10Y)

📊

Operating Expenses

146

233

253

213

214

217

📊

Operating Expenses Growth (1Y)

+0.54%

+55.11%

+125.40%

+50.26%

+29.01%

+50.40%

+60.12%

+8.26%

-15.46%

+0.07%

+1.63%

📊

Operating Expenses Growth (5Y)

+428.18%

+577.76%

+557.16%

+366.83%

+236.34%

+120.39%

+46.64%

+49.03%

📊

Operating Expenses Growth (10Y)

+1401.79%

+1394.73%

+1419.16%

📊

Sell General Administrative

121

138

137

138

130

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

-13

-15

-27

-47

-71

-95

-143

-228

-166

-117

-8

-3

📊

EBITDA Growth (1Y)

-15.91%

-84.82%

-73.81%

-50.70%

-33.41%

-50.05%

-59.06%

+26.93%

+29.51%

+93.33%

+60.66%

📊

EBITDA Growth (5Y)

-461.15%

-545.84%

-424.33%

-379.83%

-132.66%

-22.93%

+94.54%

+97.85%

📊

EBITDA Growth (10Y)

-820.25%

+47.08%

+79.18%

📊

Depreciation and Amortization

📊

Operating Income

-14

-22

-50

-75

-97

-146

-210

-187

-156

-45

-23

📊

Operating Income Growth (1Y)

-0.54%

-55.11%

-125.40%

-50.26%

-29.01%

-50.40%

-43.96%

+10.61%

+16.96%

+70.90%

+48.71%

📊

Operating Income Growth (5Y)

-428.18%

-577.76%

-557.16%

-319.72%

-149.70%

-60.72%

+68.90%

+84.05%

📊

Operating Income Growth (10Y)

-995.17%

-217.03%

-62.60%

📊

Interest Expense

📊

Pre Tax Income

-13

-15

-31

-48

-74

-99

-147

-233

-200

-178

-74

-35

📊

Tax Provision

-1

-5

-2

-0

📊

NET INCOME

-13

-15

-31

-48

-74

-99

-145

-233

-200

-183

-75

-37

📊

Net Income Growth (1Y)

-15.51%

-107.96%

-54.53%

-54.49%

-33.21%

-46.48%

-60.28%

+14.18%

+8.26%

+59.14%

+51.14%

📊

Net Income Growth (5Y)

-473.48%

-561.36%

-365.86%

-383.18%

-168.39%

-84.84%

+48.44%

+74.81%

📊

Net Income Growth (10Y)

-1312.05%

-399.47%

-144.06%

📊

Basic EPS

-0.82

-0.95

-6.29

-2

-2.88

-3.4

-4.11

-5.58

-4.39

-3.99

-1.61

-0.75

📊

Diluted EPS

-0.82

-0.95

-6.29

-2

-2.88

-3.4

-4.11

-5.58

-4.39

-3.99

-1.61

-0.77

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-11.72%
Next Earnings	--
Market cap	729.25M (USD)
EPS (TTM)	-0.75 ($)
P/E (TTM)	-20.33 ($)
Last Close	15.25

Next Earnings	--
Market cap	729.25M (USD)
EPS (TTM)	-0.75 ($)
P/E (TTM)	-20.33 ($)
Last Close	15.25 ($)

Ex-Dividend date	--
Payment date	--
Annual Dividend	--
Dividend Yield	--
Shareholders Yield	-11.72%
Next Earnings	--
Market cap	729.25M (USD)
EPS (TTM)	-0.75 ($)
P/E (TTM)	-20.33 ($)
Last Close	15.25

Next Earnings	--
Market cap	729.25M (USD)
EPS (TTM)	-0.75 ($)
P/E (TTM)	-20.33 ($)
Last Close	15.25 ($)